ES2142644T3 - Procedimiento para la obtencion de una disolucion de infusion y dialisis que contiene bicarbonato. - Google Patents

Procedimiento para la obtencion de una disolucion de infusion y dialisis que contiene bicarbonato.

Info

Publication number
ES2142644T3
ES2142644T3 ES97112089T ES97112089T ES2142644T3 ES 2142644 T3 ES2142644 T3 ES 2142644T3 ES 97112089 T ES97112089 T ES 97112089T ES 97112089 T ES97112089 T ES 97112089T ES 2142644 T3 ES2142644 T3 ES 2142644T3
Authority
ES
Spain
Prior art keywords
solution
infusion
procedure
dialysis
carbonic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97112089T
Other languages
English (en)
Inventor
Thomas Dr Knerr
Thomas Dr Wild
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fresenius Medical Care Deutschland GmbH
Original Assignee
Fresenius Medical Care Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Medical Care Deutschland GmbH filed Critical Fresenius Medical Care Deutschland GmbH
Application granted granted Critical
Publication of ES2142644T3 publication Critical patent/ES2142644T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION TRATA DE UN PROCEDIMIENTO PARA FABRICAR UNA SOLUCION DE INFUSION O DIALISIS QUE CONTIENE BICARBONATO CON UN VALOR DE PH FISIOLOGICAMENTE TOLERABLE. A FIN DE CONSERVAR, INCLUSO TRAS EL TRATAMIENTO EN CALIENTE PARA LA ESTERILIZACION, UNA SOLUCION CON UN VALOR DE PH ESTABLE Y FISIOLOGICAMENTE TOLERABLE SE INTRODUCE, SEGUN LA INVENCION, EN LA SOLUCION AL MENOS 2 MMOL/L DE UN ESTER DE ACIDO CARBONICO COMO MINIMO. LA SOLUCION SE SOMETE A UN TRATAMIENTO EN CALIENTE QUE SUPERA LOS 100 (GRADOS) C, DE MANERA QUE EL ESTER DE ACIDO CARBONICO SE DESCOMPONE CASI POR COMPLETO EN ACIDO CARBONICO Y ALCOHOL. LA INVENCION TRATA ADEMAS DEL EMPLEO DEL PROCEDIMIENTO SEGUN LA INVENCION PARA LA FABRICACION DE UNA SOLUCION DESTINADA A LA DIALISIS PERITONEAL Y UNA SOLUCION DE INFUSION O DIALISIS CON APLICACIONES MEDICAS.
ES97112089T 1996-08-01 1997-07-15 Procedimiento para la obtencion de una disolucion de infusion y dialisis que contiene bicarbonato. Expired - Lifetime ES2142644T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19631124A DE19631124A1 (de) 1996-08-01 1996-08-01 Verfahren zur Herstellung einer Bicarbonat enthaltenden Infusions- oder Dialysierlösung

Publications (1)

Publication Number Publication Date
ES2142644T3 true ES2142644T3 (es) 2000-04-16

Family

ID=7801521

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97112089T Expired - Lifetime ES2142644T3 (es) 1996-08-01 1997-07-15 Procedimiento para la obtencion de una disolucion de infusion y dialisis que contiene bicarbonato.

Country Status (5)

Country Link
US (1) US5945129A (es)
EP (1) EP0821951B1 (es)
JP (1) JP4229993B2 (es)
DE (2) DE19631124A1 (es)
ES (1) ES2142644T3 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3636468B2 (ja) * 1994-07-01 2005-04-06 バクスター、インターナショナル、インコーポレイテッド 生化学的にバランスさせた腹膜透析溶液
SE510587C2 (sv) 1997-10-07 1999-06-07 Gambro Lundia Ab Koncentrat för dialyslösning och användning därav
DE19748290B8 (de) * 1997-10-31 2009-09-03 Fresenius Medical Care Deutschland Gmbh Lösung für die Peritonealdialyse
EG24303A (en) * 1998-10-20 2009-01-12 Advanced Renal Technologies Buffered compositions for dialysis
US7670491B2 (en) 1998-10-20 2010-03-02 Advanced Renal Technologies Buffered compositions for dialysis
US6610206B1 (en) 1998-10-20 2003-08-26 Advanced Renal Technologies Buffered compositions for dialysis
US6770148B1 (en) * 1998-12-04 2004-08-03 Baxter International Inc. Peritoneal dialysis solution containing modified icodextrins
DE19912850B4 (de) 1999-03-22 2005-04-07 Fresenius Medical Care Deutschland Gmbh Lösung, insbesondere für Hämo- oder Peritonealdialyse, sowie Verfahren zu deren Herstellung
US8105258B2 (en) 1999-04-26 2012-01-31 Baxter International Inc. Citrate anticoagulation system for extracorporeal blood treatments
US6743191B1 (en) 1999-04-26 2004-06-01 Edwards Lifesciences Ag Substitution infusion fluid and citrate anticoagulation
US7186420B2 (en) 1999-04-26 2007-03-06 Edwards Lifesciences Corporation Multi-part substitution infusion fluids and matching anticoagulants
US6309673B1 (en) 1999-09-10 2001-10-30 Baxter International Inc. Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy
US20040215129A1 (en) * 1999-09-16 2004-10-28 Gambro Ab Method and cycler for the administration of a peritoneal dialysis fluid
EP1218039B1 (en) 1999-09-22 2009-02-18 Advanced Renal Technologies Use of high citrate dialysate
US7122210B2 (en) * 2002-01-11 2006-10-17 Baxter International Inc. Bicarbonate-based solutions for dialysis therapies
US7445801B2 (en) * 2002-06-07 2008-11-04 Baxter International Inc. Stable bicarbonate-based solution in a single container
US20040121982A1 (en) * 2002-12-20 2004-06-24 Leo Martis Biocompatible dialysis fluids containing icodextrins
US20050276868A1 (en) * 2004-06-10 2005-12-15 Bart Degreve Bicarbonate-based peritoneal dialysis solutions
US7935070B2 (en) * 2005-01-28 2011-05-03 Fresenius Medical Care North America Systems and methods for dextrose containing peritoneal dialysis (PD) solutions with neutral pH and reduced glucose degradation product
DE102005020327A1 (de) * 2005-04-30 2006-11-09 Multibind Biotec Gmbh Dekontaminationslösungen und deren Verwendung zur Denaturierung, Modifikation, Degradation, Solubilisierung und Entfernung von Proteinen, Nukleinsäuremolekülen und Mikroorganismen von Oberflächen
US7658952B2 (en) * 2007-10-11 2010-02-09 Baxter International Inc. Dialysis solutions containing pyrophosphates
DE102010012183A1 (de) * 2010-03-19 2011-09-22 Fresenius Medical Care Deutschland Gmbh Veresterte Polysaccharid-Osmotika
US9585810B2 (en) 2010-10-14 2017-03-07 Fresenius Medical Care Holdings, Inc. Systems and methods for delivery of peritoneal dialysis (PD) solutions with integrated inter-chamber diffuser
RU2521361C2 (ru) * 2012-04-17 2014-06-27 Общество С Ограниченной Ответственностью "Нпо "Нефрон" Раствор для бикарбонатного гемодиализа
RU2536994C1 (ru) * 2013-05-17 2014-12-27 Общество С Ограниченной Ответственностью "Нпо "Нефрон" Концентрированный кислотный компонент, набор для его получения, концентрированный раствор кислотного компонента для получения гемодиализирующего раствора и способ его получения

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2467599B1 (fr) * 1979-10-24 1983-07-29 Agronomique Inst Nat Rech Nouvelles compositions rehydratantes utiles notamment dans le traitement de la diarrhee chez le veau
US4489535A (en) * 1980-10-02 1984-12-25 Veltman Preston Leonard Materials and method for preparing dialysis solutions containing bicarbonate ions
NZ228855A (en) * 1988-04-25 1992-08-26 Hoffmann La Roche Tyrosine analogues and peptides containing them especially cholecystokinin (cck) analogues
DE3917251A1 (de) * 1989-05-26 1990-11-29 Fresenius Ag Natriumbicarbonat enthaltendes konzentrat sowie verfahren zur herstellung einer dialysierfluessigkeit
EP0437274B1 (de) * 1990-01-12 1994-05-18 Bartz, Volker Bicarbonat und Calcium enthaltende Infusions- und Dialysierlösung
DE4039471A1 (de) * 1990-12-11 1992-06-25 Braun Melsungen Ag Spezialkonzentrat fuer die bicarbonat-dialyse und seine verwendung
DE59206619D1 (de) * 1992-04-06 1996-07-25 Baxter Int Wässrige Peritonealdialyse-Lösung
JP3636468B2 (ja) * 1994-07-01 2005-04-06 バクスター、インターナショナル、インコーポレイテッド 生化学的にバランスさせた腹膜透析溶液

Also Published As

Publication number Publication date
JP4229993B2 (ja) 2009-02-25
EP0821951B1 (de) 2000-02-02
US5945129A (en) 1999-08-31
JPH1077228A (ja) 1998-03-24
DE19631124A1 (de) 1998-02-05
EP0821951A1 (de) 1998-02-04
DE59701083D1 (de) 2000-03-09

Similar Documents

Publication Publication Date Title
ES2142644T3 (es) Procedimiento para la obtencion de una disolucion de infusion y dialisis que contiene bicarbonato.
ATE298259T1 (de) Vorrichtung zur lokalen verabreichung einer arznei in einer körperhöhle
AR042795A1 (es) Fluidos de dialisis biocompatibles que contienen icodextrinas
DK30192A (da) Laegemiddelholdig matrix
ES2155473T3 (es) Composicion veterinaria que contiene un inhibidor de las bombas de protones.
ID24901A (id) Metode pengobatan keadaan terkoagulasi tinggi atau defisiensi protein c yang diperoleh
FI873075A0 (fi) Anordning och foerfarande foer bestaemning av saorlaekningsfoermaogan.
AR020610A1 (es) Utilizacion de un copolimero de acido metacrilico de tipo c segun la farmacopea us national formulary usp/nf, como agente de desagregacion y el procedimiento de fabricaion de un comprimido con dicho copolimero
ES2000428T3 (es) Procedimiento para producir un medicamento para el tratamiento de la enfermedad de alzheimer, que contiene galantamina, y dispositivo medico correspondiente.
BR0111645A (pt) Tratamento de superfìcie de dispositivo médico
UY27186A1 (es) Formulación farmacéutica
ES2151908T3 (es) Derivados del acido fenil-ciclohexano-carboxilico sustituidos con heterociclo.
DK0856312T3 (da) Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme
AR001073A1 (es) Benzoilguanidinas basicamente sustituidas procedimientos para su preparación su empleo como medicamento o agente de diagnostico asi como medicamento que las contiene
ES2041243T3 (es) Aplicacion de por lo menos un principio activo inhibidor o destructor de por lo menos un ser vivo unicelular o virus.
NO20034417D0 (no) Engangs vaginalkanyle for samtidig administrasjon av medikamenter i ulike former
AR003001A1 (es) Composicion farmaceutica estimuladora de la osteogenesis.
DE69329687T2 (de) Verwendung von aspirin zur herstellung eines arzneimittels zur verbesserung fer blutperfusion des uterus
ES2159967T3 (es) Medicamento que contiene acido delta-aminolevulinico.
MX9300767A (es) Derivados del acido amidazolilpropenoico sustituidos por sulfonilbencilo, medicamentos que los contienen y procedimiento para la obtencion de tales medicamentos.
CAMPHOR Selections.
ES2044853T3 (es) Derivados de 1,4-di-hidro-piridina, procedimiento para su fabricacion y medicamentos que contienen estos compuestos.
MD3076G2 (ro) Metodă de tratament al plăgilor necrotico-purulente la pacienţii cu picior diabetic
GB2340430B (en) Shape memory plastics articles and methods of processing same
Fernandez Comparative study of the factors that promote infection of the surgical wound and its consequences.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 821951

Country of ref document: ES